Draw the B12 Draw B12 from the vial into your syringe of choice (we recommend 0.3 ml insulin syringes for our B12 vials)
Within this region, two Sp1 binding sites have been identified, either of which is essential for promoter activity
The product is intended exclusively for research purposes and does not constitute a medicinal product, dietary supplement, or cosmetic under applicable regulations
Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S
preconception planning is important for patients with Hashimoto's disease [1] [2] Severe GI disease : Use caution or avoid in patients with severe gastrointestinal disease, including gastroparesis [1] Renal function : Monitor for dehydration and renal impairment if significant gastrointestinal adverse events occur Medication interactions : Do not use concurrently with other GLP-1 receptor agonists Patients with Hashimoto's disease considering tirzepatide should undergo comprehensive evaluation by an endocrinologist or physician experienced in managing both thyroid disorders and obesity pharmacotherapy